These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6799198)

  • 1. Clinical pharmacology of methotrexate.
    Chabner BA; Donehower RC; Schilsky RL
    Cancer Treat Rep; 1981; 65 Suppl 1():51-4. PubMed ID: 6799198
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical pharmacology of very low dose methotrexate for use in rheumatoid arthritis.
    Furst DE
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():11-4. PubMed ID: 3913770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute bone marrow suppression with low-dosage methotrexate].
    Brussaard HE; van Eijk CL; van Toorn DW; van Seters WA; de Wit RF
    Ned Tijdschr Geneeskd; 1987 Dec; 131(51):2369-72. PubMed ID: 3696284
    [No Abstract]   [Full Text] [Related]  

  • 4. The metabolic fate of tritiated methotrexate. I. Absorption, excretion, and distribution in mice, rats, dogs and monkeys.
    Henderson ES; Adamson RH; Denham C; Oliverio VT
    Cancer Res; 1965 Aug; 25(7):1008-17. PubMed ID: 4954195
    [No Abstract]   [Full Text] [Related]  

  • 5. Methotrexate tissue distribution: prediction by a mathematical model.
    Zaharko DS; Dedrick RL; Bischoff KB; Longstreth JA; Oliverio VT
    J Natl Cancer Inst; 1971 Apr; 46(4):775-84. PubMed ID: 5573769
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental study on pharmacokinetics of methotrexate and its metabolite (7-hydroxy-methotrexate) in tissue].
    Sasaki K; Hosoya R; Wang YM; Sutow WW; Fujimoto T
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1678-87. PubMed ID: 7184366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methrotrexate U.S.P. (amethopterin) and methotrexate sodium.
    Am J Hosp Pharm; 1973 Jun; 30(6):542-8. PubMed ID: 4709936
    [No Abstract]   [Full Text] [Related]  

  • 8. [Methotrexate in the treatment of psoriasis].
    Grupper C; Bourgeois-Spinasse J
    Presse Med (1893); 1970 Sep; 78(37):1631-4. PubMed ID: 5455160
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of N-acetylcysteine on methotrexate-induced oxidative renal damage in rats.
    Cetinkaya A; Kurutas EB; Bulbuloglu E; Kantarceken B
    Nephrol Dial Transplant; 2007 Jan; 22(1):284-5. PubMed ID: 16877488
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current problems of age-related pharmacology (a review of the literature)].
    Markova IV
    Farmakol Toksikol; 1981; 44(4):494-9. PubMed ID: 7026280
    [No Abstract]   [Full Text] [Related]  

  • 11. Methotrexate: clinical pharmacology, current status and therapeutic guidelines.
    Bleyer WA
    Cancer Treat Rev; 1977 Jun; 4(2):87-101. PubMed ID: 329989
    [No Abstract]   [Full Text] [Related]  

  • 12. Preliminary model for methotrexate pharmacokinetics.
    Bischoff KB; Dedrick RL; Zaharko DS
    J Pharm Sci; 1970 Feb; 59(2):149-54. PubMed ID: 5411336
    [No Abstract]   [Full Text] [Related]  

  • 13. Melatonin prevents methotrexate-induced hepatorenal oxidative injury in rats.
    Jahovic N; Cevik H; Sehirli AO; Yeğen BC; Sener G
    J Pineal Res; 2003 May; 34(4):282-7. PubMed ID: 12662351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slow release properties and liver-targeting characteristics of methotrexate erythrocyte carriers.
    Yuan SH; Ge WH; Huo J; Wang XH
    Fundam Clin Pharmacol; 2009 Apr; 23(2):189-96. PubMed ID: 19298236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-selective uptake of pravastatin in rats: contribution of a specific carrier-mediated uptake system.
    Yamazaki M; Tokui T; Ishigami M; Sugiyama Y
    Biopharm Drug Dispos; 1996 Dec; 17(9):775-89. PubMed ID: 8968530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZT glue immobilizes iodinated oil in vivo.
    Xuguang Z; Longbao X; Rui L; Renhua W
    Eur J Radiol; 2006 Nov; 60(2):287-92. PubMed ID: 16860506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate and the platelet count.
    Ogston D; Dawson AA; Philip JF
    Br J Cancer; 1968 Jun; 22(2):244-9. PubMed ID: 5660130
    [No Abstract]   [Full Text] [Related]  

  • 18. Distribution of C14-labelled arteether in kidneys and livers of experimental mice after intramuscular injection.
    Cheeramakara C; Khachonsaksumet V; Suthisai N; Nakosiri W; Songmuaeng K; Saenghirun C; Phienpicharn D; Nontprasert A
    Southeast Asian J Trop Med Public Health; 2008 Mar; 39(2):195-9. PubMed ID: 18564701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology of methotrexate.
    Bertino JR
    Med Pediatr Oncol; 1982; 10(4):401-11. PubMed ID: 6981055
    [No Abstract]   [Full Text] [Related]  

  • 20. L-Carnitine ameliorates methotrexate-induced oxidative organ injury and inhibits leukocyte death.
    Sener G; Ekşioğlu-Demiralp E; Cetiner M; Ercan F; Sirvanci S; Gedik N; Yeğen BC
    Cell Biol Toxicol; 2006 Jan; 22(1):47-60. PubMed ID: 16463019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.